The effects of hydroxyethyl starch on cultured renal epithelial cells

Anesthesia and Analgesia

Volumn 110, Issue 2, 2010, Pages 300-301

  Claus, Ralf A ^a   Sossdorf, Maik ^a   Hartog, Christiane ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; PLASMA SUBSTITUTE;

BLEEDING; CELL CULTURE; CELL VIABILITY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; EPITHELIUM CELL; HUMAN; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY INTERSTITIUM; MORTALITY; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; KIDNEY PROXIMAL TUBULE; METABOLISM; NOTE;

CELLS, CULTURED; CHEMOKINE CCL2; EPITHELIAL CELLS; HETASTARCH; HUMANS; KIDNEY TUBULES, PROXIMAL; PLASMA SUBSTITUTES;

EID: 76249097843     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181ca03a4     Document Type: Editorial

References (23)

1. Boldt J. PRO: hydroxyethylstarch can be safely used in the intensive care patient-the renal debate. Intensive Care Med 2009;35:1331-1336
2. Hartog C, Reinhart K. CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients. Intensive Care Med 2009;35:1337-1342
3. Vincent JL. The pros and cons of hydroxyethyl starch solutions. Anesth Analg 2007;104:484-486
4. Nohe B, Johannes T, Reutershan J, Rothmund A, Haeberle HA, Ploppa A, Schroeder TH, Dieterich HJ. Synthetic colloids attenuate leukocyte-endothelial interactions by inhibition of integrin function. Anesthesiology 2005;103:759-767
5. Tian J, Lin X, Zhou W, Xu J. Hydroxyethyl starch inhibits NF-kappaB activation and prevents the expression of inflammatory mediators in endotoxic rats. Ann Clin Lab Sci 2003;33:451-458
6. Feng X, Yan W, Liu X, Duan M, Zhang X, Xu J. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLPinduced sepsis in rats. J Surg Res 2006;135:129-136
7. Lv R, Zhou ZQ, Wu HW, Jin Y, Zhou W, Xu JG. Hydroxyethyl starch exhibits antiinflammatory effects in the intestines of endotoxemic rats. Anesth Analg 2006;103:149-155
8. Matharu NM, Butler LM, Rainger GE, Gosling P, Vohra RK, Nash GB. Mechanisms of the anti-inflammatory effects of hydroxyethyl starch demonstrated in a flow-based model of neutrophil recruitment by endothelial cells. Crit Care Med 2008;36:1536-1542
9. Volta CA, Alvisi V, Campi M, Marangoni E, Alvisi R, Castellazzi M, Fainardi E, Manfrinato MC, Dallocchio F, Bellini T. Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study. Anesthesiology 2007;106:85-91
10. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, Tran VD, Nguyen TH, Nguyen VC, Stepniewska K, White NJ, Farrar JJ. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877-889
11. Brunkhorst FM, Englel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139
12. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007;CD000567
13. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-916
14. Hagne C, Schwarz A, Gaspert A, Giambarba C, Keusch G. HAES in septic shock-sword of Damocles? Schweiz Med Forum 2009;9:304-306 Available at: www.medicalforum.ch
15. Zarychanski R, Turgeon AF, Fergusson DA, Cook DJ, Hebert P, Bagshaw SM, Monsour D, McIntyre LA. Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials. Open Med 2009;3:E196-209
16. Hecht-Dolnik M, Barkan H, Taharka A, Loftus J. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2009;138:703-711
17. Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 2003;123:1853-1857
18. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008;51:491-503
19. Huter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009;13:R23
20. Sossdorf M, Appelt A, Schaarschmidt B, Döring S, Claus RA, Hartog C, Lösche W. Hydroxyethyl starch solutions impair clot formation and platelet aggregation but enhance platelet surface receptor expression. Hämatologie 2008;28:A82
21. Wittlinger M, Schlaefer M, De Conno E, Roth Z'graggen B, Reyes L, Booy C, Seifert B, Burmeister MA, Spahn D, Beck- Schimmer B. The effect of hydroxyethyl starches (HES 130/0.42 and HES 200/0.5) on activated renal tubular epithelial cells. Anesth Analg 2010;110:531-540
22. Pillebout E, Nochy D, Hill G, Conti F, Antoine C, Calmus Y, Glotz D. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005;5:1120-1129
23. Eisenbach C, Schonfeld AH, Vogt N, Wente MN, Encke J, Stremmel W, Martin E, Pfenninger E, Weigand MA. Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution. Intensive Care Med 2007;33:1637-1644